GERNAY, Marie-Marie ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de diabétologie, nutrition, maladies métaboliques
Philips, Jean-Christophe ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Radermecker, Régis ; Université de Liège - ULiège > Département des sciences cliniques > Pharmacologie clinique
Paquot, Nicolas ; Université de Liège - ULiège > Département des sciences de la santé publique > Diabétologie, nutrition et maladies métaboliques
Language :
French
Title :
L’apport du système FreeStyle Libre® dans la prise en charge du patient diabétique :expérience au CHU de Liège
Alternative titles :
[en] Contribution of FreeStyle Libre® in the care of diabetic patients : experience at the CHU of Liege
Publication date :
November 2018
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Belgium
The Diabetes Control and Complications Trial Research Group.— The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
Stratton IM, Adler AI, Neil HA, et al.— Association of glycaemia with macrovascular and microvascu-lar complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 2000, 321, 405-412.
The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.—Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005, 353, 2643-2653.
Holman RR, Paul SK, Bethel MA, et al.— 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359, 1577-1589.
American Diabetes Association.— Glycemic targets: standards of medical care in diabetes. Diabetes Care, 2018, 41 (Suppl 1), S55-S64.
Gubitosi-Klug RA, Braffett BH, White NH, et al.—-Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study. Diabetes Care, 2017, 40, 1010-1016.
Dunn TC, Xu Y, Hayter G, Ajjan RA.— Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests. Diabetes Res Clin Pract, 2018, 137, 37–46.
Pearson SM, Ajjan RA.— Flash glucose monitoring in younger individuals with diabetes: accuracy and patient experience in real-world settings. Diabetes Technol Ther, 2018, 20, 4-5.
Reach G.— Foreword: Continuous glucose monitoring, an old dream finally achieved (or near about). Médecine des maladies Métaboliques, 2016, 10, 611-613.
Hanaire H.— What continuous glucose monitoring brings to insulin pump. Médecine des maladies Métaboliques, 2016, 10, 631-635.
Al Hayek AA, Robert AA, Al Dawish MA.— Evaluation of FreeStyle Libre Flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes, 2017, 10, 1-6.
Hirsch IB. - Glycemic variability and diabetes complications: does it matter? Of course it does! Diabetes Care, 2015, 38, 1610-1614.
Slattery D, Choudhary P.— Clinical use of continuous glucose monitoring in adults with type 1 diabetes. Diabetes Technol Ther, 2017, 19, S55-S61.
Chetty VT, Almulla A, Odueyungbo A, Thabane L.—The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabetes Technol Ther, 2008, 81, 79-81.
Rodbard D.— Continuous Glucose Monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther, 2017, 19, S25-S37.
Joubert M.— Continuous glucose monitoring systems: a comparative assessment. Medecine des maladies Métaboliques, 2016, 10, S55-S61.
Ólafsdóttir AF, Attvall S, Sandgren U, et al.— A clinical trial of the accuracy and treatment experience of the flash glucose monitor FreeStyle Libre in adults with type 1 diabetes. Diabetes Technol Ther, 2017, 19, 164-171.
Matuleviciene V, Joseph JI, Andelin M, et al.— A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther, 2014, 16, 759-767.
Amiel SA, Pursey N, Higgins B, Dawoud D; Guideline Development Group.— Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance. BMJ, 2015, 351, 1-4.
Ajjan RA, Cummings MH, Jennings P, et al.— Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice. Diab Vasc Dis Res, 2018, 15, 175 -184.
Reddy, Jugnee N, El Laboudi A, et al.— A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med, 2018, 35, 483-490.
Wood A, O’Neal D.— Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenge. Intern Med J, 2018, 48, 499-508.
Haak T, Hanaire H, Ajjan R, et al.— Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. Diabetes Ther, 2017, 8, 573-586.
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al.— Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: a multicenter, non-masked, randomised controlled trial. Lancet, 2016, 388, 2254-2263.
